These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 21370412)
21. Multicenter COMPACT study of COMplications in patients with sickle cell disease and utilization of iron chelation therapy. Jordan L; Adams-Graves P; Kanter-Washko J; Oneal PA; Sasane M; Vekeman F; Bieri C; Magestro M; Marcellari A; Duh MS Curr Med Res Opin; 2015 Mar; 31(3):513-23. PubMed ID: 25495135 [TBL] [Abstract][Full Text] [Related]
22. Daily functioning and quality of life in children with sickle cell disease pain: relationship with family and neighborhood socioeconomic distress. Palermo TM; Riley CA; Mitchell BA J Pain; 2008 Sep; 9(9):833-40. PubMed ID: 18550443 [TBL] [Abstract][Full Text] [Related]
23. Red blood cell transfusion therapy for sickle cell patients with frequent painful events. Hilliard LM; Kulkarni V; Sen B; Caldwell C; Bemrich-Stolz C; Howard TH; Brandow A; Waite E; Lebensburger JD Pediatr Blood Cancer; 2018 Dec; 65(12):e27423. PubMed ID: 30152184 [TBL] [Abstract][Full Text] [Related]
24. Mental health disorders influence admission rates for pain in children with sickle cell disease. Myrvik MP; Burks LM; Hoffman RG; Dasgupta M; Panepinto JA Pediatr Blood Cancer; 2013 Jul; 60(7):1211-4. PubMed ID: 23151972 [TBL] [Abstract][Full Text] [Related]
25. Psychological aspects and hospitalization for pain crises in youth with sickle-cell disease. Tsao JC; Jacob E; Seidman LC; Lewis MA; Zeltzer LK J Health Psychol; 2014 Mar; 19(3):407-16. PubMed ID: 23407129 [TBL] [Abstract][Full Text] [Related]
26. Pain experience of children with sickle cell disease who had prolonged hospitalizations for acute painful episodes. Jacob E; Mueller BU Pain Med; 2008; 9(1):13-21. PubMed ID: 18254762 [TBL] [Abstract][Full Text] [Related]
27. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083 [TBL] [Abstract][Full Text] [Related]
28. National trends in incidence rates of hospitalization for stroke in children with sickle cell disease. McCavit TL; Xuan L; Zhang S; Flores G; Quinn CT Pediatr Blood Cancer; 2013 May; 60(5):823-7. PubMed ID: 23151905 [TBL] [Abstract][Full Text] [Related]
29. Daily home opioid use in adults with sickle cell disease: The PiSCES project. Smith WR; McClish DK; Dahman BA; Levenson JL; Aisiku IP; de A Citero V; Bovbjerg VE; Roberts JD; Penberthy LT; Roseff SD J Opioid Manag; 2015; 11(3):243-53. PubMed ID: 25985809 [TBL] [Abstract][Full Text] [Related]
30. Fatigue in Children With Sickle Cell Disease: Association With Neurocognitive and Social-Emotional Functioning and Quality of Life. Anderson LM; Allen TM; Thornburg CD; Bonner MJ J Pediatr Hematol Oncol; 2015 Nov; 37(8):584-9. PubMed ID: 26479993 [TBL] [Abstract][Full Text] [Related]
31. Somatic symptom burden in adults with sickle cell disease predicts pain, depression, anxiety, health care utilization, and quality of life: the PiSCES project. Sogutlu A; Levenson JL; McClish DK; Rosef SD; Smith WR Psychosomatics; 2011; 52(3):272-9. PubMed ID: 21565599 [TBL] [Abstract][Full Text] [Related]
32. Hospitalizations for painful episodes: association with school absenteeism and academic performance in children and adolescents with sickle cell anemia. Eaton ML; Haye JS; Armstrong FD; Pegelow CH; Thomas M Issues Compr Pediatr Nurs; 1995; 18(1):1-9. PubMed ID: 8707636 [TBL] [Abstract][Full Text] [Related]
33. Examining Biopsychosocial Factors in Relation to Multiple Pain Features in Pediatric Sickle Cell Disease. Schlenz AM; Schatz J; Roberts CW J Pediatr Psychol; 2016 Sep; 41(8):930-40. PubMed ID: 26869665 [TBL] [Abstract][Full Text] [Related]
34. Association between Participants' Characteristics, Patient-Reported Outcomes, and Clinical Outcomes in Youth with Sickle Cell Disease. Badawy SM; Barrera L; Cai S; Thompson AA Biomed Res Int; 2018; 2018():8296139. PubMed ID: 30105252 [TBL] [Abstract][Full Text] [Related]
35. Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease. Jennings JE; Ramkumar T; Mao J; Boyd J; Castro M; Field JJ; Strunk RC; DeBaun MR Am J Hematol; 2008 Aug; 83(8):640-3. PubMed ID: 18506703 [TBL] [Abstract][Full Text] [Related]
37. Healthcare utilization and hydroxyurea adherence in youth with sickle cell disease. Badawy SM; Thompson AA; Holl JL; Penedo FJ; Liem RI Pediatr Hematol Oncol; 2018; 35(5-6):297-308. PubMed ID: 30636474 [TBL] [Abstract][Full Text] [Related]
38. Management of severe chronic pain with methadone in pediatric patients with sickle cell disease. LeBlanc Z; Vance C; Payne J; Zhang J; Hilliard L; Lebensburger JD; Howard TH Pediatr Blood Cancer; 2018 Aug; 65(8):e27084. PubMed ID: 29749702 [TBL] [Abstract][Full Text] [Related]
39. Use of the new pediatric PROMIS measures of pain and physical experiences for children with sickle cell disease. Singh A; DasGupta M; Simpson PM; Panepinto JA Pediatr Blood Cancer; 2019 May; 66(5):e27633. PubMed ID: 30688017 [TBL] [Abstract][Full Text] [Related]
40. Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease. Zempsky WT; Loiselle KA; McKay K; Blake GL; Hagstrom JN; Schechter NL; Kain ZN Pediatr Blood Cancer; 2008 Aug; 51(2):265-8. PubMed ID: 18386784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]